Healthcare

Decoding the Stakeholder Landscape at Teladoc Health (NYSE:TDOC)

Highlights,Institutions manage 68% of Teladoc Health reflecting significant interest.,Hedge funds control 5.5% of shares, driving active engagement in...

Exploring Stryker's (NYSE:SYK) Financial Metrics and Stock Performan...

Highlights,Stryker stock rise 11% in three months, reflecting financial strength.,Strong retention supports growth alongside consistent dividends.,Red...

HCA Healthcare (NYSE:HCA) Strengthens Position with Dividend Increas...

Highlights,HCA Healthcare trades at $332.18, within a 52-week range of $281.61 to $417.14.,Institutional investors own 62.73% of the company's shares....

Could Eli Lilly’s Stock Struggles Reveal a Deeper Issue?

Highlights:,Eli Lilly's market capitalization reaches $767 billion with a P/E ratio of 87.37.,The company has a current ratio of 1.27 and a debt-to-eq...

Can Integrated Healthcare Companies Thrive in Public Markets Amidst...

Highlights:,UnitedHealth Group's,(NYSE:UNH),stock saw a rise of 2% recently.,The company's market cap stands at over $500 billion.,It operates within...

Is Merck’s Recent Market Performance Signaling Deeper Concerns?

Highlights:,Merck & Co.,(NYSE:MRK),, Inc. shares opened at nearly $98 on Tuesday.,The company has a market capitalization of approximately $248 billio...

What Does Elevance Health’s Stock Decline Mean for the Future?

Highlights:,Elevance Health's stock has experienced a dip in value.,The company maintains a moderate debt-to-equity ratio and a solid liquidity positi...

What Does Abivax's 2025 Financial Calendar Reveal About Its Strategy...

Highlights:,Abivax,(NASDAQ:ABVX),has announced its 2025 financial communications calendar.,The schedule includes key reports such as the 2024 Annual B...

Piper Sandler Increases Ardelyx (NASDAQ:ARDX) Price Target to $8.00

Ardelyx Sees Analyst Adjustments Amidst Active Insider Trades

Piper Sandler Assigns "Overweight" Rating to Glaukos (NYSE:GKOS)

Glaukos Corporation: Market Confidence and Strategic Moves

Nisa Investment Advisors LLC Holds $1.47 Million in Stock Investment...

Investment Trends and Forecast for Encompass Health

Piper Sandler Sets New Price Target of $119.00 for Blueprint Medicin...

Blueprint Medicines Navigates Diverse Analysts' Ratings with Strong Market Presence

Piper Sandler experts have reduced the price target for Regeneron Ph...

Regeneron Pharmaceuticals: Navigating Market Dynamics and Institutional Moves

D. Boral Capital Reaffirms Buy Rating for Invivyd (IVVD)

Invivyd Inc.: Navigating a Dynamic Market

Clinical-Stage Progress at Nuvation Bio (NYSE:NUVB) Reflects Strateg...

Highlights,Nuvation Bio revises Q3 2025 earnings to ($0.16) per share.,Quarterly revenue recorded at $0.73 million.,Oncology pipeline includes innovat...

Baxter International (NYSE:BAX) How Debt Levels Impact Its Financial...

Highlights,Baxter International reduced its debt but still faces high liabilities.,The company's EBIT growth of 36% in the last year supports debt man...

Cardinal Health (NYSE:CAH) Strength in Healthcare Services Sector

Highlights,Cardinal Health price target raised to $142.00.,Quarterly earnings exceed expectations with $1.88 EPS.,Institutional activity shows growth,...

What’s Behind the Recent Dip in Revolution Medicines’ Stock Price?

Highlights:,Revolution Medicines stock opened at $40.99.,The company has a market capitalization of $6.90 billion.,RVMD stock has a 12-month low of $2...

Could Corvus Pharmaceuticals Face Challenges Ahead in Price Movement...

Highlights:,Corvus Pharmaceuticals opened at $5.28 on Monday.,The company has a market capitalization of $339.29 million.,The 1-year low and high for...

Atomi Financial Group Inc. Acquires 2,018 Shares in Cardinal Health,...

Institutional Investments Surge in Cardinal Health (NYSE:CAH)